| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/24/2001 | US6264825 Binding acceleration techniques for the detection of analytes |
| 07/24/2001 | US6263745 Flow cytometer nozzle and flow cytometer sample handling methods |
| 07/24/2001 | CA2205006C Modified green fluorescent proteins |
| 07/24/2001 | CA2142868C Chemical and microbiological test kit |
| 07/19/2001 | WO2001051925A1 A scintillation proximity assay for type ii fatty acid biosynthetic enzymes |
| 07/19/2001 | WO2001051922A2 Identification of peripheral benzodiazepine receptor binding agents |
| 07/19/2001 | WO2001051919A2 High-throughput formation, identification, and analysis of diverse solid-forms |
| 07/19/2001 | WO2001051672A2 System and method for controlling male fertility |
| 07/19/2001 | WO2001051671A2 Methods for identifying inhibitors of neuronal degeneration |
| 07/19/2001 | WO2001051670A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 07/19/2001 | WO2001051669A2 Nucleic acid binding assay and selection method |
| 07/19/2001 | WO2001051668A1 Ferrofluid based arrays |
| 07/19/2001 | WO2001051667A2 Informative nucleic acid arrays and methods for making same |
| 07/19/2001 | WO2001051666A1 Methods for diagnosing and treating heart disease |
| 07/19/2001 | WO2001051665A2 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 07/19/2001 | WO2001051664A2 Method of detecting and characterizing a neoplasm |
| 07/19/2001 | WO2001051663A2 Integrated systems and methods for diversity generation and screening |
| 07/19/2001 | WO2001051662A1 A method for detection of pathogenic organisms |
| 07/19/2001 | WO2001051661A2 A universal nucleic acid amplification system for nucleic acids in a sample |
| 07/19/2001 | WO2001051660A2 Method and kit for diagnosis of neoplastic transformation |
| 07/19/2001 | WO2001051659A2 Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders |
| 07/19/2001 | WO2001051657A2 Susceptibility gene for autoimmune disease |
| 07/19/2001 | WO2001051656A1 Use of exonuclease iii in amplification reactions by polymerase of fragments of dna |
| 07/19/2001 | WO2001051655A2 Oligonucleotides for amplifying and detecting bacterial genes for extracellular alkaline metalopeptidases (apr), neutral metalopeptidases (npr) and serin peptidases (spr) |
| 07/19/2001 | WO2001051654A2 Methods and kits for identifying elite event gat-zm1 in biological samples |
| 07/19/2001 | WO2001051653A1 Pcr-based detection of rhizoctonia cerealis |
| 07/19/2001 | WO2001051652A2 Method for identifying a mark applied on a solid body |
| 07/19/2001 | WO2001051651A2 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 07/19/2001 | WO2001051650A2 Methods for determining the presence or absence of microorganisms in lipid-containing compositions |
| 07/19/2001 | WO2001051649A2 Identification of virulence determinants |
| 07/19/2001 | WO2001051642A2 Dna modification proteins |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051635A2 Novel stra6 polypeptides |
| 07/19/2001 | WO2001051633A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | WO2001051620A2 Pullulanase variants and methods for preparing such variants with predetermined properties |
| 07/19/2001 | WO2001051619A2 Genetically modified fibroblast cell |
| 07/19/2001 | WO2001051616A2 Techniques for growth and differentiation of human pluripotent stem cells |
| 07/19/2001 | WO2001051601A2 Methods for the storage and synthesis of nucleic acids |
| 07/19/2001 | WO2001051520A2 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | WO2001051519A2 Potassium channel mutants of the saccharomyces cerevisiae yeast and the use thereof for the screening of eukaryotic potassium channels |
| 07/19/2001 | WO2001051515A2 Genes differentially expressed in breast cancer |
| 07/19/2001 | WO2001051501A1 Probes for the detection of human papillomavirus |
| 07/19/2001 | WO2001051207A1 Linear probe carrier |
| 07/19/2001 | WO2001051007A2 Nuclear packing efficiency |
| 07/19/2001 | WO2001051006A2 Cardiac-cell specific enhancer elements and uses thereof |
| 07/19/2001 | WO2001050848A2 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | WO2001050829A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001009610A8 Method to measure acyl-coenzyme a esters |
| 07/19/2001 | WO2001006261A3 Screening for therapeutic agents being scap antagonists |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005935A3 Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
| 07/19/2001 | WO2001005820A3 Method for down-regulating gdf-8 activity |
| 07/19/2001 | WO2001002549A3 Homomeric and heteromeric ampa receptors |
| 07/19/2001 | WO2001001998A3 Treatment of endometriosis with antileukoprotease |
| 07/19/2001 | WO2001001025A3 Microfabricated elastomeric valve and pump systems |
| 07/19/2001 | WO2001000870A3 Method for comparing expression patterns of genes |
| 07/19/2001 | WO2001000844A3 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 07/19/2001 | WO2000078992A3 Mass transport limited in vivo analyte sensor |
| 07/19/2001 | WO2000073431B1 Methods and compositions for measuring ion channel conductance |
| 07/19/2001 | WO2000071703A3 Inhibition of histone deacetylase |
| 07/19/2001 | WO2000065098A3 Nucleotide extension on a microarray of gel-immobilized primers |
| 07/19/2001 | WO2000065092A3 Blocking non-specific binding of granulocytes in microorganism detection |
| 07/19/2001 | WO2000058730A8 Method and device for detecting analytes in fluids |
| 07/19/2001 | WO2000058516A3 Universal arrays |
| 07/19/2001 | WO2000044782A3 Ewing's tumour antigen, nucleic acid and antibodies |
| 07/19/2001 | WO2000040749A3 Method for the detection of gene transcripts in blood and uses thereof |
| 07/19/2001 | WO2000032824A9 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 07/19/2001 | US20010008936 Oligonucleotides having chiral phosphorus linkages |
| 07/19/2001 | US20010008931 Reducing electrode impedance of implantable biosensors by coating the surface with uniform hydrogel (polyurea, polyurethane) which allows unimpeded water movement |
| 07/19/2001 | US20010008887 Incubating sample under sufficient conditions to enrich target pathogen population in sample, immunoselecting target pathogen from sample, amplifying nucleic acid sequences specific to target pathogen |
| 07/19/2001 | US20010008766 Heterogeneous binding assay |
| 07/19/2001 | US20010008763 Binding |
| 07/19/2001 | US20010008762 Electrode capture of nucleic acid |
| 07/19/2001 | US20010008761 Using digitized signals; matched ion polynucleotide chromatography |
| 07/19/2001 | US20010008759 Contacting target cells with member of antibody phage display library |
| 07/19/2001 | US20010008625 Receptor binding conjugates |
| 07/19/2001 | US20010008615 Dispensing tool; substrate with wells; vesicle elements or pins |
| 07/19/2001 | US20010008217 Multiplex flow assays preferably with magnetic particles as solid phase |
| 07/19/2001 | DE10101543A1 Enhancing the antitumor activity of an amygdalin-containing material, especially loquat kernels, comprises roasting the material with far infrared radiation and fermenting it with microorganisms |
| 07/19/2001 | DE10001529A1 Stabilisierte Coenzym-Lösungen und deren Verwendung zur Bestimmung von Dehydrogenasen bzw. deren Substrate The stabilized coenzyme solutions and their use for the determination of dehydrogenases or their substrates |
| 07/19/2001 | DE10001101A1 Neue für das ptsH-Gen codierende Nukleotidsequenzen New coding for the ptsH gene nucleotide sequences |
| 07/19/2001 | DE10000629A1 Verfahren zur Identifizierung einer auf einen festen Körper aufgebrachten Markierung A method for identifying an applied onto a solid body label |
| 07/19/2001 | DE10000161A1 Determining test substances that inhibit protease, involves incubating cells expressing fusion protein having substrate with cleavage site for protease and reporter, measuring cleaved reporter and comparing with standard |
| 07/19/2001 | DE10000001A1 DNA-Matrizes und deren Verwendung zur Untersuchung von Individuen einer Population DNA matrices and their use for analysis of individuals in a population |
| 07/19/2001 | CA2406901A1 Identification of peripheral benzodiazepine receptor binding agents |
| 07/19/2001 | CA2406722A1 Dna modification proteins |
| 07/19/2001 | CA2397741A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397391A1 Informative nucleic arrays and methods for making same |
| 07/19/2001 | CA2397341A1 Ferrofluid based arrays |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2397207A1 Novel stra6 polypeptides |
| 07/19/2001 | CA2397199A1 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | CA2397176A1 A method for detection of pathogenic organisms |
| 07/19/2001 | CA2397069A1 Linear probe carrier |
| 07/19/2001 | CA2396996A1 Genetically modified fibroblast cell |